(Q37702622)

22 August 2017

1 reference

title

Nitrogen sparing therapy revisited 2009. (English)

1 reference

22 August 2017

Gregory M Enns

1

1 reference

22 August 2017

publication date

13 February 2010

1 reference

Molecular Genetics and Metabolism

22 August 2017

published in

1 reference

22 August 2017

volume

100 Suppl 1

1 reference

22 August 2017

page(s)

S65-71

1 reference

Current strategies for the management of neonatal urea cycle disorders

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.007

Survival after treatment with phenylacetate and benzoate for urea-cycle disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.007

Neurologic outcome in children with inborn errors of urea synthesis. Outcome of urea-cycle enzymopathies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.007

Neurologic damage and neurocognitive dysfunction in urea cycle disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.007

New pathways of nitrogen excretion in inborn errors of urea synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.007

Alternative pathway therapy for urea cycle disorders: twenty years later

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.007

Arginine therapy of argininosuccinase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.007

Amino Acid Acylation: A Mechanism of Nitrogen Excretion in Inborn Errors of Urea Synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.007

Treatment of inborn errors of urea synthesis: activation of alternative pathways of waste nitrogen synthesis and excretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.007

Treatment of episodic hyperammonemia in children with inborn errors of urea synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.007

Alternative pathway therapy for urea cycle disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.007

Prospective treatment of urea cycle disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.007

Hyperammonemia in urea cycle disorders: role of the nephrologist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.007

Phenylacetate and benzoate clearance in a hyperammonemic infant on sequential hemodialysis and hemofiltration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.007

Effective hemodialysis and hemofiltration driven by an extracorporeal membrane oxygenation pump in infants with hyperammonemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.007

Urea cycle defects: management and outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.007

Diagnosis, symptoms, frequency and mortality of 260 patients with urea cycle disorders from a 21-year, multicentre study of acute hyperammonaemic episodes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.007

Effect of alternative pathway therapy on branched chain amino acid metabolism in urea cycle disorder patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.007

Identification of phenylbutyrylglutamine, a new metabolite of phenylbutyrate metabolism in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.007

Outcome and survival of 88 patients with urea cycle disorders: a retrospective evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.007

Continuous venovenous hemodiafiltration in neonatal onset hyperammonemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.007

Renal replacement therapy in the treatment of confirmed or suspected inborn errors of metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.007

Emergency treatment of neonatal hyperammonaemic coma with mild systemic hypothermia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.007

Prenatal benzoate treatment in urea cycle defects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.007

Long-term outcome following pediatric liver transplantation for metabolic disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.007

Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single-center experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.007

Living donor liver transplantation for pediatric patients with inheritable metabolic disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.007

Cell-based therapies for metabolic liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.007

Hyperammonemia-induced toxicity for the developing central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.007

Therapeutic use of carbamylglutamate in the case of carbamoyl-phosphate synthetase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.007

Cross-sectional multicenter study of patients with urea cycle disorders in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.007

10.1016/J.YMGME.2010.02.007

7 January 2021

Identifiers

DOI

1 reference

22 August 2017

1 reference